Cinolazepam

Jump to: navigation, search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Cinolazepam

Articles

Most recent articles on Cinolazepam

Most cited articles on Cinolazepam

Review articles on Cinolazepam

Articles on Cinolazepam in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cinolazepam

Images of Cinolazepam

Photos of Cinolazepam

Podcasts & MP3s on Cinolazepam

Videos on Cinolazepam

Evidence Based Medicine

Cochrane Collaboration on Cinolazepam

Bandolier on Cinolazepam

TRIP on Cinolazepam

Clinical Trials

Ongoing Trials on Cinolazepam at Clinical Trials.gov

Trial results on Cinolazepam

Clinical Trials on Cinolazepam at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cinolazepam

NICE Guidance on Cinolazepam

NHS PRODIGY Guidance

FDA on Cinolazepam

CDC on Cinolazepam

Books

Books on Cinolazepam

News

Cinolazepam in the news

Be alerted to news on Cinolazepam

News trends on Cinolazepam

Commentary

Blogs on Cinolazepam

Definitions

Definitions of Cinolazepam

Patient Resources / Community

Patient resources on Cinolazepam

Discussion groups on Cinolazepam

Patient Handouts on Cinolazepam

Directions to Hospitals Treating Cinolazepam

Risk calculators and risk factors for Cinolazepam

Healthcare Provider Resources

Symptoms of Cinolazepam

Causes & Risk Factors for Cinolazepam

Diagnostic studies for Cinolazepam

Treatment of Cinolazepam

Continuing Medical Education (CME)

CME Programs on Cinolazepam

International

Cinolazepam en Espanol

Cinolazepam en Francais

Business

Cinolazepam in the Marketplace

Patents on Cinolazepam

Experimental / Informatics

List of terms related to Cinolazepam

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cinolazepam[1] (marketed under the brand name Gerodorm)[2] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as an hypnotic. Cinolazepam is not approved for sale in the United States or Canada.

See also

References

  1. US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
  2. Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006.

Linked-in.jpg